You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Adam covers proteomics and life science mass spectrometry for GenomeWeb.
While some remain concerned that the bill will reduce labs' leverage with payors, provisions like the use of arbitration for disputes are a win for providers.
The companies have launched a 5,600 subject study to look at whether the test is able to improve outcomes and reduce costs among Anthem beneficiaries.
Demand for SARS-CoV-2 testing sent lab revenues soaring while changes in patterns of patient care and regulations that could have impacts for years to come.
While SARS-CoV-2 test demand will likely remain strong well into 2021, the question of what to do with the built-up capacity in a post-COVID-19 environment looms.
The company is using collaborations with several medical centers to explore how flexible robotics platforms could further automate the clinical laboratory.
In a session on Monday, lab heads recounted struggles they faced ramping up testing and offered ideas for avoiding similar issues in the future.
With the EUA, LabCorp is able to sell the test kit directly to consumers without a prescription, making it the first over-the-counter COVID-19 test in the US.
The firm has grown its SomaScan platform to measure 7,000 proteins and will have developed around 20 clinical tests on the platform by the end of the year.
Test capacity, particularly for rapid antigen testing, is set to explode in Q1 2021, but home and asymptomatic assays remain few and far between.
New CMS billing rules and the rise of COVID-19 case numbers makes managing SARS-CoV-2 test turnaround times even more urgent for clinical laboratories.